Careers • News • Contact us •
Nov 09, 2026
From 11:30 AM to 12:30 PM
Shane Harding, PhD
Associate Professor
Departments of Medical Biophysics, of Immunology, and of Radiation Oncology
University of Toronto
Princess Margaret Cancer Centre
University Health Network
This conference is hosted by Javier Di Noia, PhD. This conference is part of the 2026-2027 IRCM conference calendar.
About this conference
I will present recently published and unpublished data that concentrate on two different stories.
The first will centre on pattern recognition receptors activated by DNA damage, including the prototypical cGAS-STING axis. Emerging evidence now implicates additional PRRs that sense RNA (e.g. RIG-I, MDA5) and specific nucleic acid structures (e.g. ZBP1) in damage-associated cytokine production. I will present data that demonstrate the integration of these seemingly discrete pathways into signalling nexus culminating in cytokine production. We newly implicate inflammasome signaling in this network and create a holistic model invoking cell cycle checkpoints and transitions as key gatekeepers of these responses.
In the second part, I will focus on how DNA replication is a key vulnerability upstream of cytokine induction and discuss mechanisms by which this emerges. As part of this, I will discuss new systems we are developing to better understand how epigenetic features are disrupted or retained as cells cope with ongoing DNA damage.
About Shane Harding
Dr. Shane Harding is a Senior Scientist at the Princess Margaret Cancer Centre and an Associate Professor in the Departments of Medical Biophysics, Immunology and Radiation Oncology at the University of Toronto. He was recently named the Canadian Research Chair, Tier II in Radiation Biology. Dr. Harding is the Chair of the Cancer Biology and Imaging Program at Princess Margaret and co-leads the STARS21 training program.
To make sure you don't miss any of the IRCM conferences, sign up now for our newsletter!
© Montreal Clinical Research Institute, Année.All rights reserves. | Privacy policy | Terms of use | Web site by Agence Riposte